Robert W. Sims, MBA
Chief Executive Officer
Military veteran with 20 years of progressive industry experience involving design, development, and launch of device, diagnostic and therapeutic products across multiple specialties.
Manya Deehr, JD
Chief Legal Officer
25 years of collaborative experience facilitating debt Financing and IPO activity for drug discover, development and commercialization deals in excess of $25B.
Tre Thompson
Chief Operations Officer
18 years of experience as a pharmaceutical executive serving in sales and marketing roles to include product development, team building, commercialization, managed-care contracting and trade negotiations.
Shanta Bantia, PhD
Chief Science Officer
20+ years in R&D, grant procurement, and clinical trial operations; Dr. Bantia has raised an excess of $200M via grants, holds multiple U.S. patents, and has advanced several compounds to market.
Scott Sweazy, MD
Chief Medical Officer
A regarded thought leader with 30+ years of medical practice who has served as a pioneering advisor for first-to-market offerings that enhance patient experiences and improve medical outcomes.